Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.19.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash $ 103,332 $ 25,000
Prepaid expenses 120,233  
Total current assets 223,565 25,000
Deferred offering costs associated with the proposed public offering 451,998 89,354
Total assets 675,563 114,354
Current liabilities:    
Accounts payable 219,708 18,000
Accrued expenses 196,300 74,048
Note payable to related party 250,000  
Due to related party 988  
Total current liabilities 666,996 92,048
Commitments and contingencies
Shareholders' Equity    
Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 7,187,500 shares issued and outstanding at March 31, 2019 and December 31, 2018 (1) [1] 719 719
Additional paid-in capital 24,281 24,281
Accumulated deficit (16,433) (2,694)
Total stockholders' equity [1] 8,567 22,306
Total Liabilities and Shareholders' Equity $ 675,563 $ 114,354
[1] This number includes up to 937,500 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On April 8, 2019, the underwriters fully exercised their over-allotment option; thus, the 937,500 Founder Shares were no longer subject to forfeiture.